Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rosti

Showing results (121-130 of 198) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patientsL Mercatali, V Valenti, D Calistri, et al.
Bone Marrow Transplantation|January 1, 1991
Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative StudyG Rosti, A Zaccaria, N Testoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsC Massard, A Kramar, J Beyer, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation--results of a European cooperative studyA Zaccaria, G Rosti, N Testoni, et al.
Bone Marrow Transplantation|January 11, 2007
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysisF Palandri, M Amabile, G Rosti, et al.
Bone Marrow Transplantation|August 1, 1996
Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantationS Testa, A Manna, A Porcellini, et al.
Bone Marrow Transplantation|January 1, 1991
BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patientsA Guerrasio, A Zaccaria, C Rosso, et al.
Haematologica|June 28, 2000
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantationG Martinelli, V Montefusco, N Testoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow TransplantationN Kröger, A R Zander, G Martinelli, et al.
British Journal of Haematology|February 1, 1994
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case reportG Visani, P Tosi, P L Zinzani, et al.
Pageof 20

Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patientsL Mercatali, V Valenti, D Calistri, et al.
Bone Marrow Transplantation|January 1, 1991
Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative StudyG Rosti, A Zaccaria, N Testoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsC Massard, A Kramar, J Beyer, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation--results of a European cooperative studyA Zaccaria, G Rosti, N Testoni, et al.
Bone Marrow Transplantation|January 11, 2007
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysisF Palandri, M Amabile, G Rosti, et al.
Bone Marrow Transplantation|August 1, 1996
Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantationS Testa, A Manna, A Porcellini, et al.
Bone Marrow Transplantation|January 1, 1991
BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patientsA Guerrasio, A Zaccaria, C Rosso, et al.
Haematologica|June 28, 2000
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantationG Martinelli, V Montefusco, N Testoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow TransplantationN Kröger, A R Zander, G Martinelli, et al.
British Journal of Haematology|February 1, 1994
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case reportG Visani, P Tosi, P L Zinzani, et al.
Pageof 20